Fat Burner Blend, a clear mix of liquid peptides inside a vial against a grey backdrop.
A woman holds out oversized jeans to indicate significant weight loss and fat burning.
Fat Burner Blend, a clear mix of liquid peptides inside a vial against a grey backdrop.
A woman holds out oversized jeans to indicate significant weight loss and fat burning.
Burn & Tone

Fat Burner

Torch visceral fat & tone muscle

Fat Burner is the go-to fat-burning and metabolism-boosting blend; designed to deliver optimal results for patients focused on targeted fat loss and body recomposition. It combines AOD-9604, MOTS-C, and Tesamorelin; three compounds that address fat metabolism through distinct biological mechanisms, from lipolysis stimulation and cellular energy optimization to visceral fat reduction through growth hormone-mediated pathways.

Unlike most peptide protocols administered in the evening, Fat Burner is taken each morning on an empty stomach to align with the body's fasted metabolic state and maximize fat oxidation.
Fat Burner
  • Overview
  • Specifications
  • Targets visceral fat (belly fat) and increases metabolism
  • Stimulates lipolysis (fat cell breakdown)
  • Supports deeper sleep
  • Helps with bone density
  • Supports lipid metabolism
  • Promotes a balanced inflammatory response
  • Supports heart health
  • Increases calories burned by boosting metabolism
  • Supports bone and cartilage repair
  • Protects against age, diet, and obesity-dependent insulin resistance
  • AOD-9604
  • CB4211
  • Tesamorelin
  • 20IU SubQ
  • Monday-Friday (a.m. - best on empty stomach)
  • 5 or 10 weeks

Fat Burner is administered as a subcutaneous (SubQ) injection, with a 30G/31G syringe at the prescribed dosage.

Injection Tutorial

How Fat Burner Works

Fat Burner approaches fat metabolism from three simultaneous angles; AOD-9604 triggers the breakdown of existing fat cells and prevents new ones from forming, MOTS-C optimizes how the body processes and burns energy at the cellular level, and Tesamorelin targets visceral adipose tissue through growth hormone stimulation. Each compound contributes a specific and non-redundant mechanism, making the formulation more comprehensive than any single fat-targeting compound could achieve alone.

AOD-9604 is a synthetic fragment of the human growth hormone molecule, specifically the region responsible for HGH's fat-metabolizing properties. It stimulates lipolysis—the breakdown of stored fat cells into free fatty acids the body can use as fuel—and simultaneously inhibits lipogenesis, the process by which the body forms new fat cells. Critically, AOD-9604 produces these effects without influencing blood sugar levels or insulin response, addressing a key limitation of full human growth hormone therapy and making it suitable for a wider range of patients.

MOTS-C is a mitochondrial-derived peptide encoded within mitochondrial DNA, making it biologically distinct from the other compounds in the protocol. It regulates how the body selects and burns fuel by activating the AMPK energy-sensing pathway and promoting fatty acid oxidation over glucose utilization. This shifts the body's metabolic preference toward stored fat as a primary energy source, supporting insulin sensitivity and metabolic flexibility; within Fat Burner Blend, MOTS-C ensures the body is primed to process and burn the fat mobilized by AOD-9604 efficiently.

Tesamorelin is a stabilized GHRH analog that stimulates growth hormone release with a demonstrated specificity for visceral adipose tissue. Visceral fat accumulates deep in the abdominal cavity, is metabolically disruptive, and resists conventional diet and exercise interventions; Tesamorelin addresses it directly through GH-mediated fat metabolism, complementing the lipolytic and metabolic mechanisms of the other compounds in the protocol.

Fat Burner is administered as a subcutaneous injection five mornings per week on an empty stomach. Fasted-state administration maximizes the fat-oxidizing conditions under which lipolytic compounds perform most effectively. Your RegenMD provider establishes your dosing protocol based on your metabolic profile and goals, and monitors your response across the five or ten-week program.

What This Means For You

  • Stimulates lipolysis and fat cell breakdown
  • Inhibits formation of new fat cells
  • Targets visceral abdominal fat specifically
  • Optimizes cellular fat and energy metabolism
  • Improves insulin sensitivity
  • Promotes healthy lipid metabolism and cardiovascular health
  • Encourages a balanced inflammatory response
  • Strengthens bone density and cartilage health

Frequently Asked Questions

Fat Burner Blend is a three-compound peptide protocol using AOD-9604, MOTS-C, and Tesamorelin to target fat metabolism from multiple biological angles simultaneously. AOD-9604 drives lipolysis and inhibits fat cell formation, MOTS-C optimizes cellular energy metabolism and insulin sensitivity, and Tesamorelin addresses visceral fat accumulation through growth hormone stimulation. The protocol is administered five mornings per week on an empty stomach over a five or ten-week program.

AOD-9604 is derived from the specific segment of the human growth hormone molecule responsible for its fat-metabolizing function, isolated from the regions that influence insulin and glucose. By targeting only the lipolytic mechanism of HGH, it stimulates fat cell breakdown and inhibits new fat formation while leaving blood sugar regulation entirely unaffected. This selectivity distinguishes it from full growth hormone therapy and makes targeted fat reduction accessible without the metabolic trade-offs associated with broader HGH protocols.

MOTS-C is a mitochondrial-derived peptide that acts as a metabolic regulator, governing which fuel source the body prioritizes for energy. By activating the AMPK pathway and promoting fatty acid oxidation, it shifts the body's metabolic preference toward stored fat. Within Fat Burner Blend, MOTS-C addresses metabolic efficiency; where AOD-9604 breaks down fat cells and Tesamorelin targets visceral deposits, MOTS-C ensures the body is metabolically primed to process that mobilized fat rather than defaulting back to glucose utilization.

Fasted-state administration enhances the effectiveness of lipolytic compounds by aligning with the body's natural fat-burning conditions. When fasting, insulin levels are low and the body is already drawing on stored fat for energy; introducing lipolytic peptides at this moment amplifies an existing metabolic process rather than competing with food-driven insulin activity. Morning dosing also coincides with naturally elevated cortisol levels that support fat mobilization, making both the timing and fasted requirement deliberate components of the protocol.

Both protocols include Tesamorelin and target body composition, but their emphasis and broader mechanisms differ.

Define Stack is formulated around growth hormone optimization through Sermorelin, IGF-1, and Tesamorelin; visceral fat reduction is one outcome among several that include lean tissue preservation, anti-aging, and recovery.

Fat Burner Blend is more specifically focused on fat metabolism, pairing AOD-9604's direct lipolytic action and MOTS-C's cellular metabolic optimization with Tesamorelin's visceral fat targeting. Patients whose primary objective is fat reduction rather than broader hormonal recomposition may find Fat Burner Blend better suited to their goals.

Getting Started Is Easy

Step 1: Consultation

A consultation to explore your goals, answer questions, and outline your wellness plan.

Step 2: Evaluation

Meet with a provider for a personalized evaluation and tailored peptide treatment plan.

Step 3: Activation

Finalize your order, receive treatment details, and begin your wellness journey.

Book a Consulation